Discover this podcast and so much more

Podcasts are free to enjoy without a subscription. We also offer ebooks, audiobooks, and so much more for just $11.99/month.

2015 San Antonio Breast Cancer Symposium: Arimidex, Tamoxifen, and Recurrence Risk After DCIS

2015 San Antonio Breast Cancer Symposium: Arimidex, Tamoxifen, and Recurrence Risk After DCIS

FromBreastcancer.org Podcast


2015 San Antonio Breast Cancer Symposium: Arimidex, Tamoxifen, and Recurrence Risk After DCIS

FromBreastcancer.org Podcast

ratings:
Length:
11 minutes
Released:
Oct 19, 2016
Format:
Podcast episode

Description

In this podcast, Marisa Weiss, M.D., Breastcancer.org’s chief medical officer, explains a study that looked at the effectiveness of Arimidex and tamoxifen for reducing risk after DCIS surgery and radiation, as well as the side effects of each medicine. The study was presented at the 2015 San Antonio Breast Cancer Symposium, December 8-12.
Listen to the podcast to hear Dr. Weiss explain:

what DCIS is

why postmenopausal women should be reassured no matter which of these medicines they’re taking

the side effects of each medicine
Released:
Oct 19, 2016
Format:
Podcast episode

Titles in the series (100)

Breastcancer.org is a nonprofit organization dedicated to providing the most reliable, complete, and up-to-date information about breast cancer. Our mission is to help women and their loved ones make sense of the complex medical and personal information about breast cancer, so they can make the best decisions for their lives. Breastcancer.org podcasts offer unique insights on prevention, treatment, research, and other breast cancer topics from our medical experts and invited guests.